Diabetic Retinopathy

Over time, high blood sugars can cause damage to retinal vessels and vision loss from diabetic retinopathy.

What is Diabetes Mellitus?

Diabetes is commonly known as elevated blood sugar. It occurs in young people who have trouble producing a substance called insulin that regulates blood sugar, as well as in older people who develop resistance to insulin as they age. Young diabetics are often referred to as Type 1, while older diabetics are ofte referred to as Type 2. There are also some diabetics who exhibit characteristics of both Type 1 and Type 2 diabetes. All types of diabetics suffer similar effects of elevated blood sugar.
When diabetes is uncontrolled it damages blood vessels throughout the body. The longer a person is diabetic and the more poorly the blood sugar levels are controlled, the more likely that person is to suffer blood vessel damage. As diabetes worsens, it first affects the smallest blood vessels, called capillaries, throughout the body. Some of the locations in the body where tiny capillaries are the most important include the kidneys, the nerves in the legs, feet, and hands, and in the light-sensing tissue of the eye called the retina.

What is Diabetic Retinopathy?

The earliest sign of small blood vessel damage in the retina is background diabetic retinopathy, also known as non-proliferative diabetic retinopathy. Background diabetic retinopathy occurs as small blood vessel disease becomes visible in the retina, and your eye doctor can see small aneurysms or hemorrhages (also known as "blood spots") in the retinal tissue at this stage. Most diabetics with background diabetic retinopathy do not know that they have this sign of advancing diabetes, since it does not always affect the vision when it is mildly or moderately severe. However, early detection of background diabetic retinopathy is crucial, as it helps the patient's primary care doctor or endocrinologist (diabetic disease specialist) know the status of the diabetic blood vessel damage throughout the body. The diagnosis of background diabetic retinopathy also lets the patient's eye doctor know that the patient is at a higher risk of vision loss than a patient without background diabetic retinopathy. The guidelines of the American Diabetes Association and American Academy of Ophthalmology reflect that all diabetics should have a dilated eye exam regularly in an effort to detect background diabetic retinopathy while it is still in its early stages.

What is a Diabetic Eye Examination?

When a patient comes to the retinal office for a diabetic eye exam, there are sometimes special imaging tests recommended by the doctor in addition to the dilated eye exam. These tests can include specific pictures of the eye with both regular color digital cameras and special laser cameras. Retinal tomography, or an evaluation of the retinal thickness and the retinal layers, is a unique technology often used to assess the structure and health of the diabetic retina. Fluorescein angiography is another specialized imaging test that allows for detailed visualization of the tiny retinal blood vessels as well as leakage from areas that are diseased. Sometimes an ultrasonic picture of the back of the eye is obtained. During your visit, your doctor will decide which of these tests are important for assessment of the retina. Not every test is recommended at every visit.

What can I do to Preserve Vision?

The cornerstone of saving vision in diabetes remains excellent blood sugar control. Over the last 2 generations, there has been ample, repeated evidence that keeping the blood sugar at an appropriate level, controlling blood pressure, and monitoring cholesterol and fats in the blood are the most effective ways to stave off diabetic retinopathy. It is very important that every diabetic has a good relationship with their primary care team and makes every effort to optimize their diabetic health. A healthy diet, regular exercise several times each week, routine at-home blood sugar monitoring as directed by your diabetic doctor, and ongoing compliance with diabetic medications are the most important part of saving vision in diabetes.

What is Background Diabetic Retinopathy?

If diabetes remains poorly controlled, background diabetic retinopathy advances as there is more and more small blood vessel damage. The small blood vessels continue to collapse and result is varying degrees of retinal ischemia, or poor blood flow to the retinal tissue due to the absence of normal blood vessel supply. Essentially, progressing diabetic retinopathy is like placing a tourniquet on the retina a slowly tightening it. There is currently no technology to restore the lost blood vessels. The lack of these blood vessels itself can cause irreversible vision loss and often limits the vision in diabetics.

What is Diabetic Macular Edema?

, There are two treatable processes that occur as there is less and less normal retinal blood flow. The first is called diabetic macular edema, which means swelling in the retina associated with diabetes. This swelling can blur and distort the vision. The swelling occurs because the walls of the small blood vessels are progressively more damaged in diabetes, and there is leakage of blood and fluid into the cells of the retina.

Read more

What is Proliferative Diabetic Retinopathy?

The second treatable process in diabetic retinopathy is the growth of abnormal new blood vessels in the eye. This process is called proliferative retinopathy. The abnormal new blood vessels in the eye probably appear in response to progressive absence of normal blood vessels, and this is an even more ominous process than diabetic macular edema. Often there is both diabetic macular edema and proliferative diabetic retinopathy in the same patient at the same time. The abnormal new blood vessels seen in proliferative retinopathy are fragile and often will bleed into the vitreous jelly filling the back of the eye. This process is called vitreous hemorrhage, and patients will often see hundreds of spots, swirls, or lines when vitreous hemorrhage begins. Sometimes the hemorrhage can be so dense that there is severe blurring of vision. As the abnormal new blood vessels continue to grow, they get denser and thicker. This process can lead to tugging or traction on the retina, and that is termed a diabetic tractional retinal detachment. Diabetic retinal detachment is the most serious and advanced stage of diabetic retinopathy. Abnormal new blood vessel growth in the eye can be treated in its earlier stages with laser therapy. The laser technique is much different than that applied to diabetic macular edema.

Read more

What is a Vitreous Hemorrhage?

Patients with diabetes develop weak blood vessels in the retina that are prone to bleeding. If bleeding occurs into the vitreous cavity, patients will see many tiny floaters and develop moderate to severe vision loss. The blood inside the eye doesn't harm the eye but it does block the vision. Blood inside the eye will sometimes absorb within a few weeks or months. When the blood absorb the vision improves. If the blood doesn't asborb, vitrecotmy surgery can be performed to improve the vision. Because of the risk of surgery, most surgeons wait anywhwere from one month to 6 months depending on the situation to see if the blood will clear without surgery.

Read more

What is a Diabetic Tractional Retinal Detachment?

Patients with proliferative diabetic retinopathy sometimes develop a tractional retinal detachment. This can occur when scar tissue grows on the surface of the retina and then contracts or is pulled forwward in the eye by the vitreous. When this happens, the retina, which is stuck to the diabetic scar tissue, pulls away from the back of the eye and away from its blood supply. The vision declines and the retina suffers. Tractional retinal detachments can usually be prevented if sufficient pan-retinal laser is administered before the scar tissue progresses. Once there is a tractional retinal detachment surgery can be helpful.

Read more

Diabetic Retinopathy NEWS

Below are current articles from a Google News Feed on Diabetic Retinopathy

Eyenuk debuts AI-assisted diabetic retinopathy screening  Medical Design & Outsourcing

Artificial intelligence vision-screening company Eyenuk (Woodland Hills, Calif.) said it has launched an AI-powered diagnostic *service* for diabetic retinopathy.

Digital image processing software for diagnosing diabetic retinopathy | OPTH  Dove Medical Press

Tanapat Ratanapakorn,1 Athiwath Daengphoonphol,2 Nawapak Eua-Anant,2 Yosanan Yospaiboon1 1KKU Eye Center, Department of Ophthalmology, Faculty ...

FDA AI Challenge: How To Assess Safety And Effectiveness : Shots - Health News  NPR

When Merdis Wells visited the diabetes clinic at the University Medical Center in New Orleans about a year ago, a nurse practitioner checked her eyes to look for ...

Glycemic Threshold for Diabetic Retinopathy Differs By Ethnicity  Diabetes In Control

Future studies should be designed to assess sociodemographic variables and how these influence the risk of diabetic retinopathy and glycemic threshold.

Eyenuk launches AI diabetic retinopathy screening service  Healio

Eyenuk has launched its EyeScreen Human + AI Diagnostic *Service* for diabetic retinopathy, according to a press release.The artificial intelligence technology ...

Diabetic Retinopathy: Assessing the Armamentarium for Improved Detection and Treatment  Healio

Learning Objectives: Upon successful completion of this activity, participants should be better able to: Utilize imaging techniques that aid in the early diagnosis, ...

Rapid Response From Retina World Congress – Transitioning Treatment in Diabetic Retinopathy  Healio

Learning Objectives: Upon successful completion of this activity, participants should be better able to: Examine new evidence regarding the treatment of ...

VIDEO: PRP, anti-VEGF both play roles in management of diabetic retinopathy  Healio

WAIKOLOA, Hawaii — At Retina 2019, Michael S. Ip, MD, of the David Geffen School of Medicine and medical director of Doheny Image Reading Center in Los ...

Proper diabetic retinopathy (DR) monitoring improves health and saves money  Open Access Government

Petri Huhtinen from Organisation Optomed OY Ltd argues that proper diabetic retinopathy (DR) monitoring improves health and saves money.

Statins associated with lower risk of retinopathy in patients with diabetes  Healio

Prevalence of diabetic retinopathy was lower in a population of patients with type 2 diabetes and dyslipidemia who were on statin therapy than in those who ...

Diabetic Retinopathy & Eye Screenings  Endocrinology Advisor

Patients with type 1 or type 2 diabetes are at risk for developing diabetic retinopathy. Eye screening programs are important to preserve vision.

Proliferative Diabetic Retinopathy Market to Expand At 9.5% CAGR from 2017-2026, Due To Growing Prevalence of Diabetes – TMR  GlobeNewswire

Unhealthy Eating Habits have led to the Rising Incidence of Proliferative Diabetic Retinopathy.

Global Diabetic Retinopathy Market 2019 Outlook: Players Abbott Laboratories, Alimera Science, Allergan plc, Ampio Pharmaceuticals.  Global Industry Journal

Thorough evaluation of Global Diabetic Retinopathy Market considering rivalry, segments, revenue outcome, regional markets, and robust players.

Plants May Offer Prevention Benefits for Vision Loss in Patients with Diabetes  Pharmacy Times

Investigators from the University of Surrey in the United Kingdom and the Eugene and Marilyn Glick Eye Institute at Indiana University School of Medicine in ...

Diagnostic test accuracy of diabetic retinopathy screening | BMC Ophthalmology  MD Linx

Internal Medicine Article: Diagnostic test accuracy of diabetic retinopathy screening by physician graders using a hand-held non-mydriatic retinal camera at a ...

Plant compounds could provide the answer for blindness caused by diabetes, say experts  Science Daily

Compounds from a group of plants could have the answer to treating several causes of blindness, new research suggests.

Role of peripheral pan-retinal photocoagulation in diabetic macular ed | OPTH  Dove Medical Press

Ahmad M Mansour,1,2 Khalil El Jawhari,3 J Fernando Arevalo4 1Department of Ophthalmology, American University of Beirut, Beirut, Lebanon; 2Department of ...

Association between lipid accumulation product and diabetic retinopath | DMSO  Dove Medical Press

Association between lipid accumulation product and diabetic retinopathy based on a community-based survey in Chinese with type 2 diabetes.

Diabetic Retinopathy Market Overview, In-Depth Analysis, Growth Factors, Size, Share, Global Industry Forecast to 2023  Market Research Gazette

Market Highlights. Diabetic retinopathy is an eye disease among the diabetic patients. It is of two types, namely, non-proliferative diabetic retinopathy and ...

Global Proliferative Diabetic Retinopathy Market: Development History, Current Analysis and Estimated Forecast to 2025  Market Research Publisher

Global Proliferative Diabetic Retinopathy Market offers a wide range of market dynamics like current trends (2019), estimated forecast (2025), segmentation by ...

Nature Could Provide the Answer for Blindness Caused by Diabetes  R & D Magazine

Mother Nature could have the answer to treating several causes of blindness.

Patients treated with aflibercept experienced greater improvements in NPDR  Healio

FORT LAUDERDALE, Fla. — The proportion of patients with a 2 or more-step improvement in non-proliferative diabetic retinopathy scores was significantly ...

Panretinal Photocoagulation Does Not Change Macular Perfusion in Eyes With Proliferative Diabetic Retinopathy  Healio

Ophthalmic Surgery, Lasers and Imaging Retina | BACKGROUND AND OBJECTIVE:To quantify and compare the vessel density (VD) in the superficial capillary ...

UAMS screening initiative aims to save vision of diabetes patients  Log Cabin Democrat

Patients with diabetes visiting University of Arkansas of Medical Science (UAMS) Family Medicine Clinics throughout the state will soon receive a new screening ...

Global Diabetic Retinopathy Market Set For Rapid Industry Growth, To Reach Around USD 9.3Bn By 2024  Industry News Center

The Market Research Group Announced The Analysis Report “Diabetic Retinopathy Market – by Type (Non-Proliferative Diabetic Retinopathy and Proliferative ...

Before New Artificial Intelligence Can Start Making Diagnoses, The FDA Demands A Broad Range Of Requirements  Kaiser Health News

Michael Abramoff, an ophthalmologist, spent years developing a computer algorithm that could scan retina images for early signs of diabetic retinopathy. It made ...

Answer to Degenerative Blindness Might Lie Inside Plants  Interesting Engineering

Scientists are on the way to developing a treatment for degenerative blindness using compounds from plants. The study shows that some plants can be used to ...

Superior Health Foundation presents spring awards  Sault Ste. Marie Evening News

More than $107000 in grants awarded to organizations across the Upper Peninsula.

Nineteen Yale affiliates win Fulbright awards  Yale News

Recipients of Fulbright awards are selected on the basis of academic and professional achievement, as well as their record of *service* and leadership potential.

Belfast researchers identify protein that could improve treatment for diabetic retinopathy and AMD  Optician Online

Researchers from Queen's University Belfast have found a new way of treating major eye diseases caused by the unusual growth of new blood vessels.

Diabetic Eye Testing Market 2026: Top Key Players Novarand, Heidelberg Engineering, Inc.  Amazing Newspaper

Diabetic eye disease comprises a group of eye-related problems that affect people with diabetes. Eye examination provides the effective clue for detecting ...

Eye Care Supplements Market Expected to show Enthralling Growth of 10.8% CAGR by 2023 with Biosyntrx Inc., Nordic Naturals Inc., Bristol-Myers Squibb Company, Healths Harmony USA Supplements LLC etc. |  Medgadget

A Broad Analysis of the "Worldwide Eye Care Supplements Market “methodology of the leading organizations in the exactness of import/export utilization,

Diabetic Retinopathy Market to Showcase Vigorous Demand during the Forecast Period  Market Research Gazette

Diabetes is the chronic condition associated with abnormally high level of glucose in the blood. Insufficient or non production of insulin in pancreas causes ...

Awareness campaign to prevent diabetic retinopathy  Millennium Post

Kolkata: A diabetic retinopathy screening camp was conducted by Health and Family Welfare department and eye department of Eastern Railway's B.R. Singh ...

Global Diabetic Retinopathy Treatment Market 2019 – Regeneron Pharmaceuticals, ThromboGenics, Genentech, Bayer Healthcare, Alimera Sciences  Biz Trends 24

We have recently published a detailed market research study focused on the “Diabetic Retinopathy Treatment Market” across the global, regional and country ...

Global Diabetic Retinopathy Market 2019- Alimera Science, Allergan plc, Ampio Pharmaceuticals., Bayer AG  Global Industry Reports

Global Diabetic Retinopathy Market report provides a wide range of economical, insightful, and powerful mechanisms to increase demand in the Diabetic ...

Global Diabetic Retinopathy Market 2019 Size & Growth: Players Actavis, PSivida, Ampio Pharmaceuticals, ThromboGenics  Global Industry Reports

Global Diabetic Retinopathy Market research report aims to group various profound studies which consider contemporary trends in the global Diabetic ...

Global Diabetic Retinopathy Market Projected to Attain USD 9.3 Billion By 2024: Zion Market Research  ZMR Industry Journal

Zion Market Research always aims at offering their clients an in-depth analysis and the best research material of the various market. This new report on the ...

(2019-2025) Global Diabetic Retinopathy Treatment Market – Top Vendors, Market Segment By Treatment Type (Medicines,Laser Surgery, Vitrectomy)  National News Times

The report titled “Global Diabetic Retinopathy Treatment Market 2019” gives a proper understanding of global Diabetic Retinopathy Treatment industry.

Global Diabetic Retinopathy Market may blast to USD 9.3Billion By 2024  ZMR Industry Journal

All you need to know, new report on “Diabetic Retinopathy Market – by Type (Non-Proliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy) and ...

Diabetic Retinopathy Treatment Market 2019 Industry Survey, Market Size, Competitive Analysis, Outlook and Forecasts To 2025  News Industry USA

The report offers an in-depth understanding of the Diabetic Retinopathy Treatment market, this is often done through the analysis of things that are poignant the ...

How Artificial Intelligence can do a health check  Economic Times

Fitness startups are trying to mimic human intelligence through their products and the benefits are plenty.

Artificial intelligence group DeepMind readies first commercial product  Financial Times

DeepMind, the British artificial intelligence group, has built a working prototype of a device that can diagnose complex eye diseases in real time, in a major step ...

Google, Verily using AI to screen for diabetic retinopathy in India  Healthcare IT News

The machine learning algorithm can also help with screening for diabetic macular edema, a boon for patients in a country where physicians are in short supply.

More Diabetic Retinopathy Screening? Primary Care May Be the Answer  MedPage Today

Primary care may be an untapped resource for diabetic retinopathy screening, a new study suggested. In a survey of over 3,200 adults with diabetes, nearly 88% ...

Statins May Prevent Diabetic Retinopathy in People with Diabetes  EndocrineWeb

Individuals with diabetes who were taking a statin for high blood cholesterol have the added benefit of reducing their risk of developing diabetic retinopathy, and ...

Novartis' speedy brolucizumab review tees up battle with Eylea, Lucentis  FiercePharma

Look out, Roche and Regeneron—Novartis eye candidate brolucizumab is on its way. Monday, the FDA said it had granted the wet age-related macular ...

FDA Clears AI Device for Diabetic Retinopathy Diagnosis  DARKDaily.com - Laboratory News

FDA clearance of an AI system for diagnosing diabetic retinopathy using retinal images shows medical potential of deep learning and algorithmic analysis.

Diet Soda Linked to Increased Risk for Diabetic Retinopathy  Medscape

Diet soda, but not regular soda, was linked to increased risk for proliferative diabetic retinopathy, a study found; further studies are needed to confirm these ...

Diet Soda Associated with Increased Risk for Diabetic Retinopathy, Study  dLife.com

New findings show that drinking diet soda may increase the risk for proliferative diabetic retinopathy (PDR), a severe type of diabetic eye disease, according to ...

Aerpio Shares Plummet after Lead Candidate Fails Phase IIb Diabetic Retinopathy Trial  Genetic Engineering & Biotechnology News

Aerpio Pharmaceuticals acknowledged the failure of its lead pipeline candidate in a Phase IIb trial in patients with moderate to severe non-proliferative diabetic ...

Diabetic Retinopathy Treatment Industry 2019 Research Report Forecast 2025  Big Times News

Diabetic retinopathy, also known as diabetic eye disease, is a common retinal complication that arises in diabetic patients due to the damage caused to the ...

India Fights Diabetic Blindness With Help From A.I.  The New York Times

A partnership with Google is part of a global effort to build and deploy systems that can detect signs of illness and disease in medical scans.

Anti-VEGF injections may play increasing role in treatment of diabetic retinopathy  Healio

Ocular Surgery News | Patients with diabetic macular edema and moderately severe to severe nonproliferative diabetic retinopathy, as determined on the ...

Global Diabetic Retinopathy Treatment Market (2019-2025) Future Scope - Top Vendors, Market Segment By Disease Type ( Proliferative Diabetic Retinopathy treatment, Non Proliferative Diabetic Retinopathy treatment)  News Industry USA

The analysis report provides the wonderful outline of Global “Diabetic Retinopathy Treatment“ Market 2019 and predicts future market trends throughout the ...

AI Supports Diagnosis of Diabetic Retinopathy  Technology Networks

Technology Networks is an internationally recognised publisher that provides access to the latest scientific news, products, research, videos and posters.

Eyenuk, Inc. Combines Artificial Intelligence Disease Detection with Human Grading to Launch the EyeScreen™ Human + AI Diagnostic Service  Business Wire

Eyenuk, Inc., announced today the launch of the EyeScreen™ Human + AI Diagnostic *Service* for diabetic retinopathy.

Helen Newberry Joy Hospital receives grant  UPMatters.com

Like Local 3 News on Facebook: Helen Newberry Joy Hospital is happy with the grant it was awarded this week by the Superior Health Foundation. According to ...

Aflibercept Benefits Bevacizumab-Unresponsive Diabetic Retinopathy Patients  MD Magazine

A new analysis of an ongoing clinical study offers insights for treating retinal vein occlusion in poor responders to bevacizumab.

Statin Therapy Reduces Risk for Diabetic Retinopathy in Type 2 Diabetes  The Cardiology Advisor

HealthDay News – For Taiwanese patients with type 2 diabetes and dyslipidemia, statin therapy is associated with a reduced risk for diabetic retinopathy, ...

Proliferative Diabetic Retinopathy Therapeutics Market Healthcare Analysis 2019 to 2025  Market Trends

The Global Proliferative Diabetic Retinopathy Therapeutics Market Research Report Forecast 2019-2025: Is a valuable source of insightful data for business ...

Google launches India program to screen diabetics for eye conditions that can cause blindness  CNBC

Google and Verily teamed up to develop a screening tool for conditions that can cause preventable eye disease in adults. It is now being used at an eye hospital ...

Diabetic retinopathy position statement promotes prevention, early detection, control  Healio

A new position statement by the American Diabetes Association recommends intensive glycemic control and regular screening for prevention and early ...

Diet soda consumption associated with increased risk of diabetic retinopathy  Healio

Researchers found that patients with diabetes who consumed more than four cans per week of a diet soft drink had a more-than-twofold risk of having ...

Global Retinal Disorders Treatment Market Industry: A Latest Research Report to Share Market Insights and Dynamics  Industrial Journalism

Global Retinal Disorders Treatment Market offers a wide range of market dynamics like current trends (2019), estimated forecast (2025), segmentation by types, ...

Global Diabetic Retinopathy Drug Market Research Report(2018 to 2023) By Global Marketers Research  Market Talk News

Global Diabetic Retinopathy Drug industry Outlook in global region – Investment opportunities, analysis, and forecast of Diabetic Retinopathy Drug market in ...

Clinician-AI combination is best in diagnosing diabetic retinopathy  Health Data Management

Assisted by a deep-learning algorithm, physicians were able to more accurately diagnose diabetic retinopathy—a potentially blinding eye disease—than either a ...

£40000 3D technology for York optician  The Press, York

A YORK opticians has invested £40000 in new 3D scanning technology.

Statins Cut Retinopathy Risk in Type 2 Diabetes  MedPage Today

Treatment with statins was associated with a significantly decreased risk of diabetic retinopathy in patients with type 2 diabetes and high cholesterol in a large ...

Statins May Reduce Risk of Retinopathy in Diabetes Patients  MD Magazine

Statins are already a common therapy among patients with type 2 diabetes. Its cholesterol-lowering benefits may help retain patient vision longer.

Disease Pathways for Diabetic Retinopathy Vary Between Patients  Endocrinology Network

Diabetic retinopathy is the leading cause of blindness among working adults in the United States, but disease pathways may vary between patients, new ...

How hospitals in India are helping Alphabet's AI project for diabetic retinopathy  Becker's Hospital Review

Hospitals in India are helping Alphabet build an artificial intelligence algorithm that screens patients for diabetic retinopathy.

Two Treatments, Similar Outcomes in Diabetic Retinopathy  MedPage Today

Two different approaches to treating proliferative diabetic retinopathy (PDR) led to similar improvement in visual acuity at 5 years, results of a randomized trial ...

Don't Let Diabetic Eye Disease Sneak Up on You  University of Utah Health Care

Nov 14, 2018 12:00 AM. If you are one of the 30.3 million Americans with diabetes, you are at risk for diabetic eye disease—including blindness.

FDA to Review Injection Treatment for Diabetic Retinopathy  Pharmacy Times

The FDA has accepted for review Regeneron Pharmaceuticals' supplemental Biologics License Application (sBLA) of aflibercept (EYLEA Injection) to treat ...

Deep learning-enhanced device detects diabetic retinopathy  Medical Xpress

(HealthDay)—A deep learning-enhanced device can accurately detect diabetic retinopathy (DR), according to a study published online Feb. 14 in Diabetes Care ...

Potential diabetic retinopathy treatment fails to meet phase 2b study endpoint  Healio

A treatment candidate for moderate to severe nonproliferative diabetic retinopathy failed to meet its phase 2b study primary endpoint, according to a press ...

Different risk factors predict diabetic retinopathy, nephropathy in type 2 diabetes  Healio

Progression of diabetic retinopathy is associated with increased HbA1c, whereas risk factors for diabetic nephropathy include HbA1c variability and dyslipidemia ...

Considering Three Major Developments in the Diabetes Retinopathy Industry  MD Magazine

The DR market is expected to accrue a sum of $2490 million by 2022, growing at a compound annual growth rate of 14.4% from 2014-2022.

Statin Therapy Reduces Risk for Diabetic Retinopathy in T2DM  Monthly Prescribing Reference

For Taiwanese patients with type 2 diabetes and dyslipidemia, statin therapy is associated with a reduced risk for diabetic retinopathy, according to a study ...

Regeneron and Roche Duke It out in the Diabetic Retinopathy Market  BioSpace

Regeneron Pharmaceuticals' Eylea (aflibercept) showed strongly positive data in a Phase III trial in patients with moderately severe and severe non-proliferative ...

ICO Publishes New Guidelines for Diabetic Retinopathy  MD Magazine

Importantly, they are not directed toward ophthalmologists, but at general physicians and public healthcare professionals.

Vision Care Market – Performance Survey 2028 | Johnson & Johnson, Valeant Pharmaceuticals  Amazing Newspaper

Global Vision Care Market: Overview. An upcoming report on the global vision care market by TMR Research could be a valuable source of information for major ...

BLOG: Laser still has an important role in diabetic eye disease  Healio

Ophthalmology Blogs | Mali | There is no question that the introduction of anti-VEGF agents has dramatically changed the landscape of how surgeons approach ...

Lipid‐Lowering Medication Decreases Risk of Diabetic Retinopathy in Type 2 Diabetes  dLife.com

Using lipid-lowering medication with fibrates, including fenofibrate and statins reduces not only the incidence of diabetic retinopathy in patients with Type 2 ...

Diabetic Retinopathy Predicts Higher CKD Progression Risk  Renal and Urology News

Diabetic retinopathy in patients with chronic kidney disease (CKD) is associated with an increased risk of CKD progression, according to a new study. “Routine ...

Statins, Fibrates Lower Diabetic Retinopathy Risks in Diabetes  Medscape

The use of lipid-lowering medication with fibrates, including fenofibrate (Lipidil, Abbott), and statins reduces not only the incidence of diabetic retinopathy in ...

NPDR Drug Trial Shows Positive Results  Pharmacy Times

Positive 1 year results from the Phase 3 PANORAMA trial evaluating Regeneron Pharmaceuticals' aflibercept injection (Eyelea) in patients with moderately ...

Monday, April 15, 2019  Kaiser Health News

The Adelanto ICE Processing Center houses nearly 2,000 people in California. Federal, state and watchdog reviews say the Florida-based firm that runs the ...

Analysis of Patient-Reported Barriers to Diabetic Retinopathy Follow-Up  Healio

Ophthalmic Surgery, Lasers and Imaging Retina | BACKGROUND AND OBJECTIVES:Close follow-up of diabetic retinopathy (DR) has been linked to improved ...

Proliferative diabetic retinopathy revealed using OCT angiography  Healio

Diabetic retinopathy is one of the leading causes of vision loss worldwide. Uncontrolled blood glucose levels damage retinal vasculature. Anyone with diabetes ...

Benefits with Early Treatment of Diabetic Retinopathy  MedPage Today

VANCOUVER -- Almost 60% of patients with nonproliferative diabetic retinopathy (NPDR) had at least a two-step improvement in retinopathy score when treated ...

GLP-1 Drugs Not Associated With Increased Risk of Diabetic Retinopathy, Study Finds  AJMC.com Managed Markets Network

Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with increased risk of incident diabetic retinopathy, according to a study published in ...

Study identifies barriers and enablers of diabetic retinopathy screening  Medical Xpress

A new study, conducted as part of a NIHR-funded project on diabetic retinopathy screening, has identified important barriers, and enablers, associated with ...

One-Year Results from Positive Phase 3 EYLEA Trial in Diabetic Retinopathy Presented at Angiogenesis Symposium  PRNewswire

TARRYTOWN, N.Y., Feb. 9, 2019 /PRNewswire/ -- Trial showed that early intervention with EYLEA improved diabetic retinopathy severity and prevented serious.

AI Speeds Diabetic Retinopathy Diagnosis Without Specialist  Medscape

An artificial intelligence (AI) system safely and effectively detects diabetic retinopathy (DR), a major cause of blindness, without the need for a physician to ...

Quantification of Retinal Nonperfusion Associated With Posterior Segment Neovascularization in Diabetic Retinopathy Using Ultra-Widefield Fluorescein Angiography  Healio

Ophthalmic Surgery, Lasers and Imaging Retina | BACKGROUND AND OBJECTIVE:To quantify the size and location of nonperfusion associated with posterior ...

Ophthalmology PACS Market by Standalone, Integrated, Picture Archiving, Communication System, Hospitals, Specialty Clinic to 2024 - Global Manufacturers, Industry Size, Applications, Opportunity and Forecast  openPR

Download Free PDF Brochure of Ophthalmology PACS Market Study Research Report Now at www.reportsnreports.com/contacts/requestsample.aspx?name=.

RAAS Activation Linked to Vascular Stiffening in T1D With Proliferative Retinopathy  Endocrinology Advisor

In patients with long-standing T1D and proliferative diabetic retinopathy, renin-angiotensin-aldosterone system activation may be associated with vascular ...

Glow-in-the-Dark Contact Lens Could One Day Prevent Diabetic Retinopathy  dLife.com

Researchers at Cal Tech in Pasadena, Calif., are developing a new device that may one day prevent diabetic retinopathy, the leading cause of vision loss ...

» Load more

What about Resources?

Dr. Pautler's Blog

This site is not designed to and does not provide medical advice, professional diagnosis, opinion, treatment or services to you or to any other individual. Through this site and linkages to other sites, The information provided in this site, or through linkages to other sites, is not a substitute for medical or professional care, and you should not use the information in place of a visit, call consultation or the advice of your physician or other healthcare provider.

IF YOU BELIEVE YOU HAVE A MEDICAL EMERGENCY, YOU SHOULD IMMEDIATELY CALL 911 OR YOUR PHYSICIAN. If you believe you have any other health problem, or if you have any questions regarding your health or a medical condition, you should promptly consult your physician or other healthcare provider. Never disregard medical or professional advice, or delay seeking it, because of something you read on this site or a linked website. Never rely on information on this website in place of seeking professional medical advice. You should also ask your physician or other healthcare provider to assist you in interpreting any information in this Site or in the linked websites, or in applying the information to your individual case.

Medical information changes constantly. Therefore the information on this Site or on the linked websites should not be considered current, complete or exhaustive, nor should you rely on such information to recommend a course of treatment for you or any other individual. Reliance on any information provided on this Site or any linked websites is solely at your own risk.